Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
allo, why would the controller be the only one selling? do you realize how ignorant you sound?
Allo, what data are you looking at? 2 deaths in the 20M + 1 in 4M + 1 in 10M = 4 deaths. Those are survival rates below. The inverse would be DEATHs.
Group Females Males Females
and Males Total 04+10
only
NR-00 3/3 = 100% 3/3 = 100% 6/6 = 100% 6/6 = 100%
NR-04 3/3 = 100% 3/3 = 100% 6/6 = 100%
NR-10 3/3 = 100% 3/3 = 100% 6/6 = 100% 18/18 = 100%
NR-20 3/3 = 100% 3/3 = 100% 6/6 = 100%
R-00 1/3 = 33% 2/3 = 67% 3/6 = 50% 3/6 = 50%
R-04 2/3 = 67% 3/3 = 100% 5/6 = 83% 15/19 = 79% 11/13= 85%
R-10 3/4 = 75% 3/3 = 100% 6/7 = 86%
R-20 2/3 = 67% 2/3 = 67% 4/6 = 67%
Thursday, 05/18/17 11:58:50 AM
Re: None
Post #
5048
of 5067 Go
Every Primate Injected With PLX-R18 Cells Survived ! That's Huge In The Eyes Of The Regulators ! Giddy-Up !
Gadzooks, allo - makes perfect sense, this multi-mega millionaire controller sits and trades 100 shares all day long to subvert this stock; so they can turn and buy it for...what $.75 Hmmmm.
That seems like a lot of work to only double your money....................
I think this links offers a better explanation of what is going on.
Good stuff, MT017 - and all of these fine folks are now submerged. But the good news is, they all have options to buy more at their pvs. purchase price of $1.40-1.50. I'm sure they are thrilled about the ARS data!
Remember, we ALL expected a run to $2.50 with this ARS data... There MUST be a real bad signal with the 20M R18 dose... No other explanation for this kind of silence.
So, controller(s)?
At less than 2% each, how many controllers must there be to place this must leverage on the share price?
Wow, you may be on to something here - tell us more!
allo - can you explain the 'controller' conspiracy theory to us in some detail?
Do you think they are an individual investor or a pharma company?
In order to 'control' the stock price, what # of shares or % ownership would they need to have to create this type of leverage?
Seemingly there is a mathematical equation here that could solve the riddle, Right?
Don't all >5% owners have to be listed?
Please share your knowledge with us.
FDApproved Member Level Tuesday, 05/16/17 10:01:31 AM
Re: None
Post #
4982
of 5030 Go
I'm Hoping For An Announcement Tomorrow... To Kick-Off Pluristem's Ascension
allo, what's in your hand today? Hope?
And the revenue this has driven into the company couldn't buy you Grande' House Blend from Starbucks. Hopefully another companies cells will be 'the solution' to 'save the entire population' kept in their 'pocket'. Almost criminal.
Nothing. Recyled babble. drip, drip, drip
allo - what happened to 'Today' & this week? Now it's next week? Your theme song should be 'There's always next year'. It's like that college football team that every game on their schedule is someone's homecoming game. We'll win the next one - giddy up
What happened to the 'standard boiler plate' opinion you had about the '12 month revenue outlook' on the 10Q?
Yes, at some point we all have to realize what is NOT being shared with us is the loudest signal of all. Need a complete coup of the wonder twin ceo's - get this under the leadership of people that actually know have to drive shareholder value & negotiation.
Voting mine to repeal and replace!
Bluehorsesho, very proud of you - from pumper to data driven reality! Way to turn the corner. Your credibility stock is growing faster than PSTI.
Sad, but true, I'm afraid.
tick,tock
This is embarrasing... unfounded giddiness & a 10yr old article to boot. Nothing says nothing new like nothing new. Controller, geesh. What a joke.
Hope in one hand and you know what in the other. See what is still there tomorrow.
Guess is 20M in endocrine vs paracrine showed no difference - both overwhelmed the subject - no use and they don't know what to do or how to spin it.
Getting them to Start would be good.
I'm sure they did. IF only the Agencies expressed an interest in PSTI.
R18 clearly not moving forward any time soon. Otherwise, less travel and more negotiating 'cure' data with the FDA...
Yaky Yanay !
Co-Founder and Director
EyeCue Vision Technologies Ltd.
As allo always advises, Due Dilligence. Giddy-Up!
http://www.eyecue-tech.com/index.php/about/about-eyecue
https://www.evs.co.il/
Facts:
- No MBA, MD, PhD., PharD., medical or advanced areas, Accounting?
- '0' deal-making experience, much less pharma/biotech/orphan
- No board member / Directorships other than his own co-founding
- A light-weight at best
- Holds our PSTI future in his "pocket"
Yaky Yanay
Co-Chief Executive Officer, President and Director,Pluristem Therapeutics Inc.
Age 45 Total Calculated Compensation $436,533*
*Before his promotion to Co-CEO. This person is connected to 24 board members in 3 different organizations across 3 different industries.
Any questions?
A brilliant biotech leader would be in front of the FDA, NIH and BARDA if he had "the solution" "in my pocket" for the "entire population" - not the JP on Monday. Just sayin'
I wasn't yelling at Yaki. I was yelling at Yaky.
correction: "the solution"
Thanks. Remember, he has "she solution" for "the entire population" in his pocket. That would help the stock price too.
please don't plagerize or copy my posts or I'll sue you too. Actually would like to avoid a shareholder lawsuit for something such as this. They really do happen. Hope we do see a 'surprise' soon.
Yaky. And you.
Then explain the stall. "Solution" "Save the Entire Population"
Instead we get "promissig results" - makes sense.
Even a 'conditional' or 'restricted' approval would bring revenue to PSTI quickly. LIKE it did for Amgen with Neupogen, within 6 months of their primate ARS trial. FACT. Amgen/Sanofi began selling nearly 2 years before the FDA indication (Nov 2015)- Why not us? See for yourself
BARDA seeks Amgen's Neupogen, Sanofi's Leukine for nuke attack countermeasures
This article was originally published in Scrip
27 Sep 2013
NEWS
https://scrip.pharmamedtechbi.com/SC022896/BARDA-seeks-Amgens-Neupogen-Sanofis-Leukine-for-nuke-attack-countermeasures
PUT UP OR SHUT UP - THIS IS MAKE OR BREAK - YOU HAVE IT, OR YOU DON'T
https://www.sec.gov/Archives/edgar/data/1158780/000117891317001317/0001178913-17-001317-index.htm
NO revenues expected in next 12 mos. from product sales. Doesn't sound like a buy-in from US or all of those other 'interested' countries very soon.
Then they commited fraud in filing the 10K. "No revenue from product sales in next 12 months"
Looks like more board abuse by FDApproved. Now by PM
FDApproved Member Level Sunday, 05/07/17 08:31:15 PM
Re: Auto1 post# 4824
Post #
4825
of 4825 Go
From A Broken Heart When He Found Out.....
He Received PLX-R18 And His Buddy George Received A Placebo.
Poor George !
You are posting to the Pluristem Therapeutics, Inc. (PSTI) board. Please keep your post about the stock and company. Do not post about other users or other stocks.
Your post may be removed if it contains off-topic or other content that violates the terms of the Terms of Service.
Why did one primate die in the R18 arm?
In Reply to 'FDApproved' on 'Pluristem Therapeutics, Inc. (PSTI)'
~Informational Services Support Paid By Auto 1's ~ Mom ~
You are posting to the Pluristem Therapeutics, Inc. (PSTI) board. Please keep your post about the stock and company. Do not post about other users or other stocks.
Your post may be removed if it contains off-topic or other content that violates the terms of the Terms of Service.
FDApproved - can you help us understand the leap you are trying to make connecting this to PSTI? Have R18 cells been designated MSC's or do they just fit the profile? - THX
Also, this piece was reported last year, however, the author,Thomas J. Bartosh, who designed the research and the author Joshua Beaver, who performed the research are no longer affiliated with Temple Therapeutics, LLC. Only EDMUND J. PEZALLAMD, MPH is still associated, but works for Aetna.
I no longer see this focus in the pipeline at TT, do you have any updates this year?
Allo, are you paid by eTrade? I notice they post a link under all of your posts.
Why did one primate die in the R18 arm?
Will PSTI get Orphan Designation and Fast Track Status like Amgen did with Neupogen following their Primate Study in ARS? Why or Why Not?
Thats helpful. Hopefully as you state is wasn't the 20M dose.
Will PSTI get Orphan Designation and Fast Track Status like Amgen did with Neupogen following their Primate Study in ARS? Why or Why Not?
Why did one primate die in the R18 arm?